<?xml version="1.0" encoding="UTF-8"?>
<p>The treatment of keratoconjunctivitis targets reduction in redness, itching, tearing, blurry vision, chemosis and eyelid oedema
 <sup>
  <xref rid="B14" ref-type="bibr">14</xref> , 
  <xref rid="B26" ref-type="bibr">26</xref>
 </sup> . To this end, there are a variety of topical preparations, each working on a different phase in the inflammatory process, in order to manage those signs
 <sup>
  <xref rid="B28" ref-type="bibr">28</xref>
 </sup> . The treatment of conjunctivitis includes steroids
 <sup>
  <xref rid="B23" ref-type="bibr">23</xref>
 </sup> and NSAID
 <sup>
  <xref rid="B24" ref-type="bibr">24</xref>
 </sup> . This report aimed to demonstrate that the use of anti-inflammatory NSAIDs or corticosteroid could improve the inflammatory status in eye mucosa during conjunctivitis. However, the study could not demonstrate a statistical difference between the treatments. Nevertheless, the report found a clinical trend in the third evaluation between the groups A compared to group B.
</p>
